REFERENCES
1
GIMBE Evidence for
Health: Covid monitoring.
2 Driggin E, Madhavan MV, Bikdeli B, Chuich T, Laracy J, Bondi-Zoccai G,
Brown TS, Nigoghossian CD, Zidar DA, Haythe J, Brodie D, Beckman JA,
Kirtane AJ, Stone GW, Krumholz HM, Parikh SA. Cardiovascular
Considerations for Patients, Health Care Workers, and Health Systems
During the Coronavirus Disease 2019 (COVID-19) Pandemic. J Am Coll
Cardiol 2020; .
3 Inciardi RM, Lupi L, Zaccone G, Italia L, Raffo M, Tomasoni D, Cani
DS, Cerini M, Farina D, Gavazzi E, Maroldi R, Adamo M, Ammirati E,
Sinagra G, Lombardi CM, Metra M. Cardiac Involvement in a Patient With
Coronavirus Disease 2019 (COVID-19). JAMA Cardiol 2020; .
4 Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential Effects of
Coronaviruses on the Cardiovascular System: A Review. JAMA
Cardiol 2020; .
5 Han H, Yang L, Liu R, Liu F, Wu K, Li J, Liu X, Zhu C. Prominent
changes in blood coagulation of patients with SARS-CoV-2 infection.Clinical Chemistry and Laboratory Medicine (CCLM) 2020;0 .
6 Li T, Lu H, Zhang W. Clinical observation and management of COVID-19
patients. Emerg Microbes Infect 2020; 9 : 687–90.
7 Lippi G, Plebani M, Henry BM. Thrombocytopenia is associated with
severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis.Clin Chim Acta 2020; 506 : 145–8.
8 Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, Huang H, Zhang L, Zhou X, Du
C, Zhang Y, Song J, Wang S, Chao Y, Yang Z, Xu J, Zhou X, Chen D, Xiong
W, Xu L, et al. Risk Factors Associated With Acute Respiratory Distress
Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia
in Wuhan, China. JAMA Intern Med 2020; .
9 George L Anesi et al. Coronavirus disease 2019 (COVID-19): Critical
care issues. UpToDate;
10 Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are
associated with poor prognosis in patients with novel coronavirus
pneumonia. J Thromb Haemost 2020; 18 : 844–7.
11 Lillicrap D. Disseminated intravascular coagulation in patients with
2019‐nCoV pneumonia. J Thromb Haemost 2020; 18 : 786–7.
12 Lippi G, Favaloro EJ. D-dimer is Associated with Severity of
Coronavirus Disease 2019: A Pooled Analysis. Thromb Haemost 2020;
: s-0040-1709650.
13 Feinbloom D, Bauer KA. Assessment of Hemostatic Risk Factors in
Predicting Arterial Thrombotic Events. ATVB 2005; 25 :
2043–53.
14 Pechlivani N, Ajjan RA. Thrombosis and Vascular Inflammation in
Diabetes: Mechanisms and Potential Therapeutic Targets. Front
Cardiovasc Med 2018; 5 : 1.
15 Beristain-Covarrubias N, Perez-Toledo M, Thomas MR, Henderson IR,
Watson SP, Cunningham AF. Understanding Infection-Induced Thrombosis:
Lessons Learned From Animal Models. Front Immunol 2019;10 : 2569.
16 Bunce PE, High SM, Nadjafi M, Stanley K, Liles WC, Christian MD.
Pandemic H1N1 Influenza Infection and Vascular Thrombosis.Clinical Infectious Diseases 2011; 52 : e14–7.
17 Hüzmeli C, Saglam M, Arıkan A, Doner B, Akıncı G, Candan F.
Infrarenal Aorta Thrombosis Associated with H1N1 Influenza A Virus
Infection. Case Reports in Infectious Diseases 2016;2016 : 1–3.
18 Avnon LS, Munteanu D, Smoliakov A, Jotkowitz A, Barski L.
Thromboembolic events in patients with severe pandemic influenza A/H1N1.European Journal of Internal Medicine 2015; 26 : 596–8.
19 Danzi GB, Loffi M, Galeazzi G, Gherbesi E. Acute pulmonary embolism
and COVID-19 pneumonia: a random association? European Heart
Journal 2020; : ehaa254.
20 Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment
is associated with decreased mortality in severe coronavirus disease
2019 patients with coagulopathy. J Thromb Haemost 2020; .
21 Favaloro EJ, Lippi G. Recommendations for Minimal Laboratory Testing
Panels in Patients with COVID-19: Potential for Prognostic Monitoring.Semin Thromb Hemost 2020; : s-0040-1709498.